These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 31010836)
1. Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics. Xing D; Zheng G; Pallavajjala A; Schoolmeester JK; Liu Y; Haley L; Hu Y; Liu L; Logan L; Lin Y; Pearce KE; Sattler CA; Tsai YC; Vang R; Hung CF; Wu TC; Ronnett BM Clin Cancer Res; 2019 Jul; 25(14):4516-4529. PubMed ID: 31010836 [TBL] [Abstract][Full Text] [Related]
2. Choriocarcinoma in Women: Analysis of a Case Series With Genotyping. Savage J; Adams E; Veras E; Murphy KM; Ronnett BM Am J Surg Pathol; 2017 Dec; 41(12):1593-1606. PubMed ID: 28877059 [TBL] [Abstract][Full Text] [Related]
3. Fluorescence In Situ Hybridization for the X and Y Chromosome Centromeres Helps Differentiate Between Gestational and Nongestational Choriocarcinoma in Clinically Ambiguous Cases. Whaley RD; Dougherty RE; Cheng L; Ulbright TM Arch Pathol Lab Med; 2020 Jul; 144(7):863-868. PubMed ID: 31846368 [TBL] [Abstract][Full Text] [Related]
4. Use of short tandem repeat analysis in unusual presentations of trophoblastic tumors and their mimics. Aranake-Chrisinger J; Huettner PC; Hagemann AR; Pfeifer JD Hum Pathol; 2016 Jun; 52():92-100. PubMed ID: 26980014 [TBL] [Abstract][Full Text] [Related]
5. Ovarian Intermediate Trophoblastic Tumors: Genotyping Defines a Distinct Category of Nongestational Tumors of Germ Cell Type. Xing D; Zhong M; Ye F; O'Malley MT; Li S; Vang R; Ronnett BM Am J Surg Pathol; 2020 Apr; 44(4):516-525. PubMed ID: 31688005 [TBL] [Abstract][Full Text] [Related]
6. PD-L1 Expression in Carcinosarcomas of the Gynecologic Tract: A Potentially Actionable Biomarker. Pinto A; Mackrides N; Nadji M Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):393-397. PubMed ID: 27801734 [TBL] [Abstract][Full Text] [Related]
8. Mixed serous carcinoma of the endometrium with trophoblastic differentiation: analysis of the p53 tumor suppressor gene suggests stem cell origin. Horn LC; Hänel C; Bartholdt E; Dietel J Ann Diagn Pathol; 2008 Feb; 12(1):1-3. PubMed ID: 18164407 [TBL] [Abstract][Full Text] [Related]
9. Analysis of PD-L1 expression in trophoblastic tissues and tumors. Lu B; Teng X; Fu G; Bao L; Tang J; Shi H; Lu W; Lu Y Hum Pathol; 2019 Feb; 84():202-212. PubMed ID: 30339966 [TBL] [Abstract][Full Text] [Related]
10. An Overview of the Role of Long Non-Coding RNAs in Human Choriocarcinoma. Di Fiore R; Suleiman S; Felix A; O'Toole SA; O'Leary JJ; Ward MP; Beirne J; Sabol M; Ozretić P; Yordanov A; Vasileva-Slaveva M; Kostov S; Nikolova M; Said-Huntingford I; Ayers D; Ellul B; Pentimalli F; Giordano A; Calleja-Agius J Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204445 [TBL] [Abstract][Full Text] [Related]
11. Uterine choriocarcinoma arising from serous carcinoma in a postmenopausal woman: an analysis of next-generation sequencing and PD-L1 immunochemistry. Li M; Bao L; Lu B; Ge W; Ren L Diagn Pathol; 2022 Oct; 17(1):79. PubMed ID: 36229840 [TBL] [Abstract][Full Text] [Related]
12. Using short tandem repeat analysis for choriocarcinoma diagnosis: a case series. Zhang X; Yan K; Chen J; Xie X Diagn Pathol; 2019 Aug; 14(1):93. PubMed ID: 31421690 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors. Cierna Z; Mego M; Miskovska V; Machalekova K; Chovanec M; Svetlovska D; Hainova K; Rejlekova K; Macak D; Spanik S; Ondrus D; Kajo K; Mardiak J; Babal P Ann Oncol; 2016 Feb; 27(2):300-5. PubMed ID: 26598537 [TBL] [Abstract][Full Text] [Related]
17. Gene expression profile of a newly established choriocarcinoma cell line, iC3-1, compared to existing choriocarcinoma cell lines and normal placenta. Kobayashi Y; Banno K; Shimizu T; Ueki A; Tsuji K; Masuda K; Kisu I; Nomura H; Tominaga E; Nagano O; Saya H; Aoki D Placenta; 2013 Feb; 34(2):110-8. PubMed ID: 23199791 [TBL] [Abstract][Full Text] [Related]
18. Non-gestational choriocarcinoma: unraveling the similarities and distinctions from its gestational counterpart. Mangla M; Palo S; Kanikaram P; Kaur H Int J Gynecol Cancer; 2024 Jun; 34(6):926-934. PubMed ID: 38123189 [TBL] [Abstract][Full Text] [Related]
19. Nongestational choriocarcinoma in the postpartum period: a case report. Suryanarayan K; O'Hanlan KA; Surti U; Ishwad CS; Nowels K; Letourneau D; Marina N J Pediatr Hematol Oncol; 1998; 20(2):169-73. PubMed ID: 9544172 [TBL] [Abstract][Full Text] [Related]
20. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract. Mirkovic J; McFarland M; Garcia E; Sholl LM; Lindeman N; MacConaill L; Dong F; Hirsch M; Nucci MR; Quick CM; Crum CP; McCluggage WG; Howitt BE Am J Surg Pathol; 2018 Feb; 42(2):227-233. PubMed ID: 28984674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]